Track the AtaiBeckley Inc. share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.7bn. The latest transaction was filed on 9 July 2026 (Levée d'options). Among the most active insiders: Craig Kevin James. Every trade is accessible without an account.
20
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€1m
6 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate AtaiBeckley Inc. Hold (neutral), based on 8 analysts. Average price target: US$9.09.
28Σ signal
Buys n/a€1m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
39,594 shares@ US$3.899100.0% of flowCommon StockSEC:0001140361-26-000415:0
20 of 20 declarations
Acerca de AtaiBeckley Inc.
AtaiBeckley Inc. es una empresa que cotiza en el mercado XNAS, enfocada en la investigación y desarrollo de tratamientos psicodélicos para trastornos de salud mental. Colabora con instituciones académicas y empresas para avanzar en este campo innovador.